77.01 Low-Mortality Hospitals Provide Better End-Of-Life Care for Non-Survivors After Severe Brain Trauma

E. J. Lilley1,2, J. W. Scott1, A. Krasnova1, E. Schneider1, A. H. Haider1, Z. Cooper1  1Brigham And Women’s Hospital,The Center For Surgery And Public Health,Boston, MA, USA 2Robert Wood Johnson – Rutgers,Department Of Surgery,New Brunswick, NJ, USA

Introduction: Severe traumatic brain injury (TBI) in older patients is associated with poor prognosis, with rates of mortality or functional dependence exceeding 80%. For non-survivors, aggressive, rescue-directed care may include burdensome treatments at the end of life and impede appropriate provision of hospice, an established quality marker for end-of-life (EOL) care. It is not known whether hospitals with low in-hospital mortality also deliver high-quality EOL care to non-survivors. Therefore, we sought to compare EOL care of older non-survivors with severe TBI treated at low-mortality hospitals against all others.

Methods: Using 2001-2011 Medicare data, we identified patients > 65 years with severe TBI (head AIS > 3) who survived > 1 day in-hospital. Patients at low case-volume hospitals (< 5 eligible patients per year) were excluded. Two categories of non-survivors were analyzed: those who died in-hospital and those who died < 30-days post-discharge. The primary independent variable was in-hospital mortality ranking of the treating hospital: Hospitals were divided into quartiles based on in-hospital mortality and those in the lowest quartile were considered high-performing. EOL care outcomes included intensity of treatment (gastrostomy and tracheostomy) and hospice enrollment. Outcomes of patients treated at high-performing hospitals were compared with others using multivariate Cox regression (30-day post-discharge mortality) and multivariate logistic regression models (EOL care outcomes) adjusting for age, sex, race, and comorbidity.

Results:Among 35,057 older patients hospitalized with severe TBI, 57% died in-hospital or 30-days post-discharge. By definition, in-hospital mortality was lower at high-performing hospitals than at others (36% vs. 49%), yet 30-day post-discharge mortality was the reverse: 26% in high-performing hospitals vs. 19% at others (HR 1.41 [CI 1.32-1.50], p < 0.01). Compared with patients treated at other hospitals, in-hospital non-survivors at high-performing hospitals had similar rates of gastrostomy (3.9% vs. 4.1%, OR 0.94 [CI 0.77-1.15], p = 0.57), tracheostomy (6.9% vs. 6.4%, OR 1.08 [CI 0.92-1.26], p = 0.34), and no clinically significant difference in hospice enrollment (2.2% vs. 1.6%, OR 1.38 [CI 1.05-1.83], p = 0.02). In contrast, 30-day post-discharge non-survivors at high-performing hospitals had fewer high-intensity treatments and a greater proportion were enrolled in hospice (Figure). 

Conclusion:These findings suggest that high-performing hospitals are better able to identify patients with poor prognosis and provide appropriate EOL care.